ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Abstract: SA-PO0490

Real-World Waist Circumference and Kidney Outcomes: Observational Analysis of US Veterans Affairs Data

Session Information

Category: Cardiovascular-Kidney-Metabolic Health

  • 602 Cardiovascular-Kidney-Metabolic Health: Clinical

Authors

  • Mathew, Roy O., VA Loma Linda Healthcare System, Loma Linda, California, United States
  • Fung, Enrica, Stanford Medicine, Stanford, California, United States
  • Hong, Annie V., VA Loma Linda Healthcare System, Loma Linda, California, United States
  • Sanchez, Alyssa, Loma Linda University Health, Loma Linda, California, United States
  • Infante, Sergio, Loma Linda University Health, Loma Linda, California, United States
  • Rhee, Connie, VA Greater Los Angeles Healthcare System, Los Angeles, California, United States
  • Kalantar-Zadeh, Kamyar, The Lundquist Institute, Torrance, California, United States
  • Abdi Pour, Amir, Loma Linda University Health, Loma Linda, California, United States
  • Rangaswami, Janani, Washington DC VA Medical Center, Washington, District of Columbia, United States
Background

Rigorously collected WC in the research setting had a linear relationship with the composite outcome of 40% estimated glomerular filtration rate (eGFR), end stage kidney disease (ESKD) or eGFR < 10 ml/min/1.73m2.(Chang AR BMJ 2019 Jan 10; 364:k5301). It is unclear whether routinely collected WC in clinical practice has similar relationships with kidney outcomes.

Methods

Loma Linda VA IRB provided expedited approval. This was a retrospective cohort study. Data was taken from the National US Veterans Health Administration (VHA) database, including 20,113 individuals with available WC and eGFR measured at baseline (WC date) and 5 years (5yrs) from baseline. Participants were stratified by WC tertiles (≤34, >34–40, > 41 inches[in]; minimum acceptable WC was 23 in. and maximum was 65 in.). The primary outcome was the odds of 30% or 50% decline in eGFR at 5yrs from baseline using logistic regression, adjusted for baseline body mass index, eGFR, age, diabetes status, and race/ethnicity.

Results

Average age of the population was 61 years, 23% were of Black race, 91% male, 83% with HTN and 51% with diabetes. There was a greater proportion of White individuals, and individuals with diabetes and hypertension in the higher WC group, and lower proportion of females in the higher WC group (2.5% in the highest WC group versus 8.5% in the lowest WC; p for trend < 0.001). eGFR decline over 5 yrs was faster in those in the highest WC group (Figure plot A), as well as higher in patients with diabetes (Figure plot B). Multivariable adjusted odds ratio for 50% decline or greater in eGFR at 5yrs was 1.25 (p = 0.2) for the 2nd WC group, and 1.66 (p = 0.004) for the highest WC group.

Conclusion

WC obtained in the routine clinical setting, likely with variable technique across sites, demonstrated a graded positive association with kidney function decline. WC should be routinely incorporated into nephrology practice for risk prediction.